CN106560471A - Rupatadine preparation proces - Google Patents

Rupatadine preparation proces Download PDF

Info

Publication number
CN106560471A
CN106560471A CN201610069504.8A CN201610069504A CN106560471A CN 106560471 A CN106560471 A CN 106560471A CN 201610069504 A CN201610069504 A CN 201610069504A CN 106560471 A CN106560471 A CN 106560471A
Authority
CN
China
Prior art keywords
solution
methyl
rupatadine
deca
plus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610069504.8A
Other languages
Chinese (zh)
Inventor
王康林
汪祥
黄志生
柏春雷
张成栋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pingguang Pharmaceutical Co Ltd
Original Assignee
Pingguang Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pingguang Pharmaceutical Co Ltd filed Critical Pingguang Pharmaceutical Co Ltd
Priority to CN201610069504.8A priority Critical patent/CN106560471A/en
Publication of CN106560471A publication Critical patent/CN106560471A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)

Abstract

The invention discloses a rupatadine preparation process, which comprises: S1, preparing methyl 5-methylnicotinate; S2, preparing 5-methyl-3-pyridinemethanol; S3, preparing 3-methyl-5-chloromethylpyridine hydrochloride; and S4, preparing rupatadine. According to the present invention, the preparation process has advantages of low cost, mild reaction condition, simple operation, low requirement on equipment, good product purity and high yield, and is suitable for large-scale industrial production.

Description

A kind of preparation technology of Rupatadine
Technical field
The present invention relates to Rupatadine preparing technical field, more particularly to a kind of preparation technology of Rupatadine.
Background technology
Rupatadine is that [1- [(5- methyl -3- pyridine radicals) methyl] -4- piperidines is sub- for the chloro- 6,11- dihydros -11- of 8- Base] -5H- benzos [5,6] cycloheptane simultaneously [1,2-b] pyridine.Its molecular formula is C26H26ClN3, molecular weight is 415.96, No. CAS is 158876-82-5, and fusing point is 58-61 DEG C.Rupatadine has antihistamine and antagonism The dual function of platelet activating factor, is mainly used in treatment allergic rhinitises and pollinosis, with wide Market prospect.Its structural formula is as follows:
At present, the synthetic route of Rupatadine mainly has two kinds.Route 1 is as follows:
Route 2 is as follows:
In above two route, route 1 is short compared to the circuit of route 2, and saves synthesizing amide and acyl The reduction step of amine, but the yield of route 1 is low, and reaction selectivity is not strong, is also easy to produce double bromination reactions, Purer product is arrived seldom.
The committed step of route 2 is the reduction step of synthesizing amide and amide.The method of synthesizing amide is mainly DCC HOBT carry out acid amide condensation, required dehydrant DC and raceme inhibitor C HOBT under the conditions of DMF Costly, it is relatively costly, and yield is relatively low;The by-product N of generation, N- 1,3-Dicyclohexylureas (DCU) are most In organic solvent, dissolubility is little, it is difficult to remove.The method of reducing amide has:Report in patent ES2087818 POCl is used in road3/NaBH4Used as the method for reducing agent reducing amide, the method needed column chromatography just obtain Qualified products, product purity are high, and yield is good but cumbersome, and purifying products difficulty needed chromatographic column, POCl3 Corrosivity are strong, high to equipment requirements.Describe in United States Patent (USP) No.5407941 in tetrahydrofuran solution, With lithium aluminium hydride reduction as reducing agent method of reducing, but product yield is low, and purity is poor.In Chinese patent Describe in CN1865259A in tetrahydrofuran, double hydrogen sodium aluminates are used as the method for reducing of reducing agent, but Product yield is low, purity is poor, and a class solvent load is big.
Therefore need to provide a kind of low for equipment requirements, product yield is high, and good product purity, reagent are cheap Rupatadine preparation technology.
The content of the invention
Based on the technical problem that background technology is present, the present invention proposes a kind of preparation technology of Rupatadine, Low cost of the present invention, reaction condition are gentle, simple to operate, low for equipment requirements, good product purity, yield Height, is adapted to industrialized great production.
A kind of preparation technology of Rupatadine proposed by the present invention, comprises the steps:
S1, preparation 5- methyinicotinates:5- methylnicotinic acids, methanol are mixed, Deca thionyl chloride rises Temperature, insulation, Evaporation of methanol and thionyl chloride, water on the rocks obtain solution A;The pH=7-9 of solution A is adjusted, Plus first organic solvent extraction, take organic faciess evaporation obtain 5- methyinicotinates;
S2, preparation 5- methyl -3- piconols:Magnesium chloride, potassium borohydride, tetrahydrofuran are mixed, is heated up Backflow, is cooled to room temperature and obtains solution B;The 5- methyinicotinates obtained in S1 are added in tetrahydrofuran Dissolving, adjusts temperature, and Deca solution B, insulation are cooled to room temperature and obtain solution C;Methanol is added to be quenched instead Should, evaporate tetrahydrofuran and methanol obtains concentrate D;Add water in concentrate D after mixing, it is organic plus the second Solvent extraction, takes organic faciess evaporation and obtains 5- methyl -3- piconols;
S3, -5 chloromethyl pyridine hydrochloride of preparation 3- methyl:By -3 piconol of 5- methyl obtained in S2 It is dissolved in dioxane, Deca thionyl chloride, the temperature that liquid is kept during Deca is 20-30 DEG C, is risen Temperature, insulation, evaporation obtain -5 chloromethyl pyridine hydrochloride of 3- methyl;
S4, prepare Rupatadine:Filling N2In environment, by desloratadine, potassium carbonate, N, N dimethyl first - 5 chloromethyl pyridine hydrochloride of 3- methyl obtained in amide and S3 is mixed, and is heated up, insulation, adds water to mix It is even, plus the extraction of the 3rd organic solvent, take organic faciess evaporation and obtain Rupatadine.
Preferably, in S1,5- methylnicotinic acids are 1 with the mol ratio of methanol:10-20.
Preferably, in S1,5- methylnicotinic acids are 1 with the mol ratio of thionyl chloride:1-5.
Preferably, in S1,5- methylnicotinic acids, methanol are mixed, Deca thionyl chloride is warming up to 40-100 DEG C, Insulation 2.5-7.5h, does not stop stirring, adjusts the temperature to 50-60 DEG C in Deca and insulating process, be evaporated under reduced pressure Methanol and thionyl chloride are removed, room temperature is cooled to, adds frozen water to obtain solution A;In ice bath, solution is adjusted The pH=7-9 of A, plus the extraction of the first organic solvent, take organic faciess rotary evaporation and obtain 5- methyinicotinates.
Preferably, in S1, it is preferable that thionyl chloride completion of dropping in the 10-30min.
Preferably, in S1, the pH=7-9 of solution A is adjusted with ammonia.
Preferably, in S1, the first organic solvent is ethyl acetate.
Preferably, in S1, plus the extraction of the first organic solvent, add anhydrous sodium sulfate drying in organic faciess to moisture Content is≤0.5wt%, filters, takes organic faciess rotary evaporation and obtain 5- methyinicotinates.
Preferably, in S2, the mol ratio of 5- methyinicotinates, magnesium chloride and potassium borohydride is 1:1-5: 1-5, wherein, the mol ratio of magnesium chloride and potassium borohydride is 1:1.
Preferably, in S2, magnesium chloride, potassium borohydride, tetrahydrofuran is mixed, 65-70 DEG C is warming up to, Backflow 0.5-4.5h, is cooled to room temperature and obtains solution B;The 5- methyinicotinates obtained in S1 are added into four Dissolve in hydrogen furan, it is 0-80 DEG C to adjust temperature, and Deca solution B is incubated 0.5-1.5h, Deca and insulation During do not stop stirring, be cooled to room temperature and obtain solution C;Add methanol that reaction is quenched, be warming up to 35-45 DEG C, Rotary evaporation tetrahydrofuran and methanol obtain concentrate D;Add water in concentrate D after mixing, it is organic plus the second Solvent extraction, takes organic faciess rotary evaporation and obtains 5- methyl -3- piconols.
Preferably, in S2, solution B completion of dropping in the 0.5-2h.
Preferably, in S2, the second organic solvent is ethyl acetate.
Preferably, in S2, plus the extraction of the second organic solvent, coextraction three times, merge organic faciess, plus it is anhydrous Sodium sulfate drying is filtered, takes organic faciess rotary evaporation and obtain 5- methyl -3- to being≤0.5wt% to moisture Piconol.
Preferably, in S3, the mol ratio of -3 piconol of 5- methyl and thionyl chloride is 1:1-3.
Preferably, in S3, -3 piconol of 5- methyl obtained in S2 is dissolved in dioxane, is dripped Plus thionyl chloride, the temperature that liquid is kept during Deca is 20-30 DEG C, is warming up to 60-80 DEG C, is incubated 3-5h, Stirring is not stopped in Deca and insulating process, reduction vaporization obtains -5 chloromethyl pyridine hydrochloride of 3- methyl.
Preferably, in S3,3-5h is incubated, does not stop stirring in Deca and insulating process, be cooled to 20-30 DEG C, It is evaporated under reduced pressure after removing thionyl chloride, is warming up to 60-80 DEG C, removing dioxane is evaporated under reduced pressure and obtains 3- first - 5 chloromethyl pyridine hydrochloride of base.
Preferably, in S4, desloratadine, potassium carbonate, the mol ratio of -5 chloromethylpyridine hydrochloric acid of 3- methyl are 1:1-4:1-3.
Preferably, in S4, filling N2In environment, by desloratadine, potassium carbonate, DMF Mix with -5 chloromethyl pyridine hydrochloride of 3- methyl obtained in S3, be warming up to 35-65 DEG C, be incubated 15-25h, Do not stop stirring in insulating process, add water and mix, plus the extraction of the 3rd organic solvent, take organic faciess rotary evaporation Obtain Rupatadine.
Preferably, in S4, the 3rd organic solvent is dichloromethane.
Preferably, in S4, add water and mix, plus the 3rd organic solvent carries out at least 1 time extraction, Ran Houhe And organic faciess obtain solution E, wash solution E 2-3 time with water, after stratification, take the supernatant and obtain molten Liquid F, then subnatant is solution G, adds the 3rd organic solvent to be extracted, take subnatant in solution F Solution H is obtained, Solution H and solution G mix homogeneously, rotary evaporation are obtained into Rupatadine.
Preferably, in S4, plus the extraction of the 3rd organic solvent, add anhydrous sodium sulfate drying in organic faciess to moisture Content is≤0.5wt%, filters, takes organic faciess rotary evaporation and obtain Rupatadine.
Tetrahydrofuran in above-mentioned S2 is solvent, does not specify its consumption.
Methanol in above-mentioned S2 is, for reaction is quenched, not specify its consumption.
5- methyl -3- the piconols obtained in above-mentioned S2, can pass through column chromatography or recrystallization is further carried It is pure.
Dioxane in above-mentioned S3 is solvent, does not specify its consumption.
DMF in above-mentioned S4 is solvent, does not specify its consumption.
The Rupatadine obtained in above-mentioned S4, can pass through column chromatography or recrystallization is further purified.
Above-mentioned " water " is deionized water.
The raw material and reagent that the present invention is selected is cheap and easy to get, low cost;Reaction condition is gentle, consumes energy low, behaviour Make simple, it is low for equipment requirements, it is adapted to industrialized great production;3- methyl-5-chloros methyl pyridinium chloride and ground When Luo Tading reacts, the selectivity of 3- methyl-5-chloro methyl pyridinium chlorides is higher, is difficult to generate by-product pair Chloro-product, the good product purity for obtaining, product yield are high.
Description of the drawings
Fig. 1 is a kind of synthetic route chart of the preparation technology of Rupatadine proposed by the present invention.
Specific embodiment
With reference to Fig. 1, a kind of preparation technology of Rupatadine proposed by the present invention comprises the steps:
S1, preparation 5- methyinicotinates:5- methylnicotinic acids, methanol are mixed, Deca thionyl chloride rises Temperature, insulation, Evaporation of methanol and thionyl chloride, water on the rocks obtain solution A;The pH=7-9 of solution A is adjusted, Plus first organic solvent extraction, take organic faciess evaporation obtain 5- methyinicotinates;
S2, preparation 5- methyl -3- piconols:Magnesium chloride, potassium borohydride, tetrahydrofuran are mixed, is heated up Backflow, is cooled to room temperature and obtains solution B;The 5- methyinicotinates obtained in S1 are added in tetrahydrofuran Dissolving, adjusts temperature, and Deca solution B, insulation are cooled to room temperature and obtain solution C;Methanol is added to be quenched instead Should, evaporate tetrahydrofuran and methanol obtains concentrate D;Add water in concentrate D after mixing, it is organic plus the second Solvent extraction, takes organic faciess evaporation and obtains 5- methyl -3- piconols;
S3, -5 chloromethyl pyridine hydrochloride of preparation 3- methyl:By -3 piconol of 5- methyl obtained in S2 It is dissolved in dioxane, Deca thionyl chloride, the temperature that liquid is kept during Deca is 20-30 DEG C, is risen Temperature, insulation, evaporation obtain -5 chloromethyl pyridine hydrochloride of 3- methyl;
S4, prepare Rupatadine:Filling N2In environment, by desloratadine, potassium carbonate, N, N dimethyl first - 5 chloromethyl pyridine hydrochloride of 3- methyl obtained in amide and S3 is mixed, and is heated up, insulation, adds water to mix It is even, plus the extraction of the 3rd organic solvent, take organic faciess evaporation and obtain Rupatadine.
Below, technical scheme is described in detail by specific embodiment.
Embodiment 1
A kind of preparation technology of Rupatadine, comprises the steps:
S1, preparation 5- methyinicotinates:5- methylnicotinic acids, methanol are mixed, Deca thionyl chloride rises Temperature is incubated 7.5h to 40 DEG C, does not stop stirring, adjust the temperature to 50 DEG C in Deca and insulating process, and decompression is steamed Send out and remove methanol and thionyl chloride, be cooled to room temperature, add frozen water to obtain solution A;In ice bath, adjust molten The pH=9 of liquid A, plus ethyl acetate extraction, take ethyl acetate phase rotary evaporation and obtain 5- methyinicotinates;
S2, preparation 5- methyl -3- piconols:Magnesium chloride, potassium borohydride, tetrahydrofuran are mixed, is heated up To 65 DEG C, flow back 4.5h, is cooled to room temperature and obtains solution B;By the 5- methyinicotinates obtained in S1 Dissolve in adding tetrahydrofuran, it is 0 DEG C to adjust temperature, and Deca solution B is incubated 1.5h, Deca and was incubated Do not stop stirring in journey, be cooled to room temperature and obtain solution C;Add methanol that reaction is quenched, be warming up to 35 DEG C, revolve Turn evaporation removing tetrahydrofuran and methanol obtains concentrate D;Add water in concentrate D after mixing, plus acetic acid second Ester is extracted, and is taken ethyl acetate phase rotary evaporation and is obtained 5- methyl -3- piconols;
S3, -5 chloromethyl pyridine hydrochloride of preparation 3- methyl:By -3 piconol of 5- methyl obtained in S2 It is dissolved in dioxane, Deca thionyl chloride, the temperature that liquid is kept during Deca is 30 DEG C, is heated up To 60 DEG C, 5h is incubated, in Deca and insulating process, does not stop stirring, reduction vaporization obtains -5 chloromethane of 3- methyl Ylpyridine hydrochloride;
S4, prepare Rupatadine:Filling N2In environment, by desloratadine, potassium carbonate, N, N dimethyl first - 5 chloromethyl pyridine hydrochloride of 3- methyl obtained in amide and S3 is mixed, and is warming up to 35 DEG C, is incubated 25h, Do not stop stirring in insulating process, add water and mix, add methylene chloride extraction, takes dichloromethane phase rotary evaporation Obtain Rupatadine.
Embodiment 2
A kind of preparation technology of Rupatadine, comprises the steps:
S1, preparation 5- methyinicotinates:5- methylnicotinic acids, methanol are mixed, Deca thionyl chloride rises Temperature is incubated 2.5h to 100 DEG C, does not stop stirring, adjust the temperature to 60 DEG C in Deca and insulating process, reduces pressure Methanol removed by evaporation and thionyl chloride, are cooled to room temperature, add frozen water to obtain solution A;In ice bath, adjust The pH=7 of solution A, plus ethyl acetate extraction, take ethyl acetate phase rotary evaporation and obtain 5- methyinicotinates;
S2, preparation 5- methyl -3- piconols:Magnesium chloride, potassium borohydride, tetrahydrofuran are mixed, is heated up To 70 DEG C, flow back 0.5h, is cooled to room temperature and obtains solution B;By the 5- methyinicotinates obtained in S1 Dissolve in adding tetrahydrofuran, it is 80 DEG C to adjust temperature, and Deca solution B is incubated 0.5h, Deca and insulation During do not stop stirring, be cooled to room temperature and obtain solution C;Add methanol that reaction is quenched, be warming up to 45 DEG C, Rotary evaporation removes tetrahydrofuran and methanol obtains concentrate D;Add water in concentrate D after mixing, plus acetic acid Ethyl ester is extracted, and is taken ethyl acetate phase rotary evaporation and is obtained 5- methyl -3- piconols;
S3, -5 chloromethyl pyridine hydrochloride of preparation 3- methyl:By -3 piconol of 5- methyl obtained in S2 It is dissolved in dioxane, Deca thionyl chloride, the temperature that liquid is kept during Deca is 20 DEG C, is heated up To 80 DEG C, 3h is incubated, in Deca and insulating process, does not stop stirring, reduction vaporization obtains -5 chloromethane of 3- methyl Ylpyridine hydrochloride;
S4, prepare Rupatadine:Filling N2In environment, by desloratadine, potassium carbonate, N, N dimethyl first - 5 chloromethyl pyridine hydrochloride of 3- methyl obtained in amide and S3 is mixed, and is warming up to 65 DEG C, is incubated 15h, Do not stop stirring in insulating process, add water and mix, add methylene chloride extraction, takes dichloromethane phase rotary evaporation Obtain Rupatadine.
Embodiment 3
A kind of preparation technology of Rupatadine, comprises the steps:
S1, preparation 5- methyinicotinates:1 part of 5- methylnicotinic acid, 10 parts of methanol are mixed by molar part, 5 parts of thionyl chlorides of Deca, thionyl chloride completion of dropping in the 10min, are warming up to 90 DEG C, are incubated 3h, drop Plus with insulating process in do not stop stirring, adjust the temperature to 58 DEG C, be evaporated under reduced pressure and remove methanol and thionyl chloride, Room temperature is cooled to, adds frozen water to obtain solution A;In ice bath, the pH=7.5 of solution A is adjusted with ammonia, Plus ethyl acetate extraction, add anhydrous sodium sulfate drying to moisture to be 0.5wt% in ethyl acetate phase, filter, Take ethyl acetate phase rotary evaporation and obtain 5- methyinicotinates;
S2, preparation 5- methyl -3- piconols:By molar part by 1 part of magnesium chloride, 1 part of potassium borohydride, four Hydrogen furan is mixed, and is warming up to 66 DEG C, and flow back 4h, is cooled to room temperature and obtains solution B;To obtain in 1 part of S1 5- methyinicotinates add tetrahydrofuran in dissolve, adjust temperature be 10 DEG C, Deca solution B, solution B completion of dropping in the 2h, is incubated 1.3h, does not stop stirring, be cooled to room temperature and obtain in Deca and insulating process Solution C;Add methanol that reaction is quenched, be warming up to 35 DEG C, rotary evaporation removes tetrahydrofuran and methanol is obtained Concentrate D;Add water in concentrate D after mixing, plus ethyl acetate extraction, coextraction three times, merge acetic acid Ethyl ester phase, plus anhydrous sodium sulfate drying to moisture be 0.5wt%, filter, take ethyl acetate phase rotation Evaporation obtains 5- methyl -3- piconols;
S3, -5 chloromethyl pyridine hydrochloride of preparation 3- methyl:By the 5- first that molar part will be obtained in 1 part of S2 - 3 piconol of base is dissolved in dioxane, 3 parts of thionyl chlorides of Deca, and liquid is kept during Deca Temperature is 22 DEG C, is warming up to 75 DEG C, is incubated 3.5h, does not stop stirring, be cooled in Deca and insulating process 30 DEG C, it is evaporated under reduced pressure after removing thionyl chloride, is warming up to 60 DEG C, removing dioxane is evaporated under reduced pressure and obtains 3- - 5 chloromethyl pyridine hydrochloride of methyl;
S4, prepare Rupatadine:Filling N2In environment, by molar part by 1 part of desloratadine, 1 part of potassium carbonate, - 5 chloromethyl pyridine hydrochloride of 3- methyl obtained in DMF and 3 parts of S3 is mixed, and is heated up To 40 DEG C, 23h is incubated, does not stop stirring in insulating process, add water and mix, add methylene chloride extraction 6 times, It is then combined with dichloromethane and mutually obtains solution E, washes solution E 2 times with water, after stratification, take upper strata clear Liquid obtains solution F, then subnatant is solution G, adds methylene chloride and is extracted, remove layer in solution F Clear liquid obtains Solution H, by Solution H and solution G mix homogeneously, plus anhydrous sodium sulfate drying to moisture is 0.5wt%, filters, and rotary evaporation obtains Rupatadine.
Embodiment 4
A kind of preparation technology of Rupatadine, comprises the steps:
S1, preparation 5- methyinicotinates:1 part of 5- methylnicotinic acid, 20 parts of methanol are mixed by molar part, 1 part of thionyl chloride of Deca, thionyl chloride completion of dropping in the 30min, is warming up to 60 DEG C, is incubated 7h, drop Plus with insulating process in do not stop stirring, adjust the temperature to 52 DEG C, be evaporated under reduced pressure and remove methanol and thionyl chloride, Room temperature is cooled to, adds frozen water to obtain solution A;In ice bath, the pH=8.5 of solution A is adjusted with ammonia, Plus ethyl acetate extraction, add anhydrous sodium sulfate drying to moisture to be 0.1wt% in ethyl acetate phase, filter, Take ethyl acetate phase rotary evaporation and obtain 5- methyinicotinates;
S2, preparation 5- methyl -3- piconols:By molar part by 5 parts of magnesium chlorides, 5 parts of potassium borohydrides, four Hydrogen furan is mixed, and is warming up to 69 DEG C, and flow back 1h, is cooled to room temperature and obtains solution B;To obtain in 1 part of S1 5- methyinicotinates add tetrahydrofuran in dissolve, adjust temperature be 70 DEG C, Deca solution B, solution B completion of dropping in the 0.5h, is incubated 0.7h, does not stop stirring, be cooled to room temperature and obtain in Deca and insulating process To solution C;Add methanol that reaction is quenched, be warming up to 45 DEG C, rotary evaporation removes tetrahydrofuran and methanol is obtained To concentrate D;Add water in concentrate D after mixing, plus ethyl acetate extraction, coextraction three times, merge second Acetoacetic ester phase, plus anhydrous sodium sulfate drying to moisture be 0.1wt%, filter, take ethyl acetate phase rotation Turn evaporation and obtain 5- methyl -3- piconols;
S3, -5 chloromethyl pyridine hydrochloride of preparation 3- methyl:By the 5- first that molar part will be obtained in 1 part of S2 - 3 piconol of base is dissolved in dioxane, 1 part of thionyl chloride of Deca, and liquid is kept during Deca Temperature is 28 DEG C, is warming up to 65 DEG C, is incubated 4.5h, does not stop stirring, be cooled in Deca and insulating process 20 DEG C, it is evaporated under reduced pressure after removing thionyl chloride, is warming up to 80 DEG C, removing dioxane is evaporated under reduced pressure and obtains 3- - 5 chloromethyl pyridine hydrochloride of methyl;
S4, prepare Rupatadine:Filling N2In environment, by molar part by 1 part of desloratadine, 4 parts of potassium carbonate, - 5 chloromethyl pyridine hydrochloride of 3- methyl obtained in DMF and 1 part of S3 is mixed, and is heated up To 60 DEG C, 17h is incubated, does not stop stirring in insulating process, add water and mix, add methylene chloride extraction 3 times, It is then combined with dichloromethane and mutually obtains solution E, washes solution E 3 times with water, after stratification, take upper strata clear Liquid obtains solution F, then subnatant is solution G, adds methylene chloride and is extracted, remove layer in solution F Clear liquid obtains Solution H, by Solution H and solution G mix homogeneously, plus anhydrous sodium sulfate drying to moisture is 0.1wt%, filters, and rotary evaporation obtains Rupatadine.
Embodiment 5
A kind of preparation technology of Rupatadine, comprises the steps:
S1, preparation 5- methyinicotinates:1 part of 5- methylnicotinic acid, 18 parts of methanol are mixed by molar part, 2 parts of thionyl chlorides of Deca, thionyl chloride completion of dropping in the 25min, are warming up to 70 DEG C, are incubated 6.5h, Do not stop stirring in Deca and insulating process, adjust the temperature to 54 DEG C, be evaporated under reduced pressure and remove methanol and thionyl chloride, Room temperature is cooled to, adds frozen water to obtain solution A;In ice bath, the pH=8.2 of solution A is adjusted with ammonia, Plus ethyl acetate extraction, add anhydrous sodium sulfate drying to moisture to be 0.2wt% in ethyl acetate phase, filter, Take ethyl acetate phase rotary evaporation and obtain 5- methyinicotinates;
S2, preparation 5- methyl -3- piconols:By molar part by 4 parts of magnesium chlorides, 4 parts of potassium borohydrides, four Hydrogen furan is mixed, and is warming up to 68 DEG C, and flow back 1.5h, is cooled to room temperature and obtains solution B;To obtain in 1 part of S1 To 5- methyinicotinates add tetrahydrofuran in dissolve, adjust temperature be 60 DEG C, Deca solution B is molten Liquid B completion of dropping in the 1.5h, is incubated 0.8h, does not stop stirring, be cooled to room temperature in Deca and insulating process Obtain solution C;Add methanol that reaction is quenched, be warming up to 42 DEG C, rotary evaporation removes tetrahydrofuran and methanol Obtain concentrate D;Add water in concentrate D after mixing, plus ethyl acetate extraction, coextraction three times, merge Ethyl acetate phase, plus anhydrous sodium sulfate drying to moisture be 0.4wt%, filter, take ethyl acetate phase Rotary evaporation obtains 5- methyl -3- piconols;
S3, -5 chloromethyl pyridine hydrochloride of preparation 3- methyl:By the 5- first that molar part will be obtained in 1 part of S2 - 3 piconol of base is dissolved in dioxane, 1.5 parts of thionyl chlorides of Deca, and liquid is kept during Deca Temperature be 26 DEG C, be warming up to 68 DEG C, be incubated 4.3h, do not stop in Deca and insulating process stirring, be cooled to 23 DEG C, it is evaporated under reduced pressure after removing thionyl chloride, is warming up to 75 DEG C, removing dioxane is evaporated under reduced pressure and obtains 3- - 5 chloromethyl pyridine hydrochloride of methyl;
S4, prepare Rupatadine:Filling N2In environment, by molar part by 1 part of desloratadine, 3 parts of potassium carbonate, - 5 chloromethyl pyridine hydrochloride of 3- methyl obtained in DMF and 1.5 parts of S3 is mixed, and is risen Temperature is incubated 18h to 55 DEG C, does not stop stirring in insulating process, and after adding water and mixing, add methylene chloride extraction 5 It is secondary, it is then combined with dichloromethane and mutually obtains solution E, washes solution E 3 times with water, after stratification, take Layer clear liquid obtains solution F, then subnatant is solution G, adds methylene chloride and is extracted, take in solution F Subnatant obtains Solution H, and Solution H and solution G mix homogeneously, plus anhydrous sodium sulfate drying are contained to moisture Measure as 0.2wt%, filter, rotary evaporation obtains Rupatadine.
Embodiment 6
A kind of preparation technology of Rupatadine, comprises the steps:
S1, preparation 5- methyinicotinates:1 part of 5- methylnicotinic acid, 14 parts of methanol are mixed by molar part, 4 parts of thionyl chlorides of Deca, thionyl chloride completion of dropping in the 15min, are warming up to 85 DEG C, are incubated 3.5h, Do not stop stirring in Deca and insulating process, adjust the temperature to 56 DEG C, be evaporated under reduced pressure and remove methanol and thionyl chloride, Room temperature is cooled to, adds frozen water to obtain solution A;In ice bath, the pH=7.8 of solution A is adjusted with ammonia, Plus ethyl acetate extraction, add anhydrous sodium sulfate drying to moisture to be 0.4wt% in ethyl acetate phase, filter, Take ethyl acetate phase rotary evaporation and obtain 5- methyinicotinates;
S2, preparation 5- methyl -3- piconols:By molar part by 3 parts of magnesium chlorides, 3 parts of potassium borohydrides, four Hydrogen furan is mixed, and is warming up to 67 DEG C, and flow back 3.5h, is cooled to room temperature and obtains solution B;To obtain in 1 part of S1 To 5- methyinicotinates add tetrahydrofuran in dissolve, adjust temperature be 20 DEG C, Deca solution B is molten Liquid B completion of dropping in the 1h, is incubated 1.2h, does not stop stirring, be cooled to room temperature and obtain in Deca and insulating process To solution C;Add methanol that reaction is quenched, be warming up to 38 DEG C, rotary evaporation removes tetrahydrofuran and methanol is obtained To concentrate D;Add water in concentrate D after mixing, plus ethyl acetate extraction, coextraction three times, merge second Acetoacetic ester phase, plus anhydrous sodium sulfate drying to moisture be 0.2wt%, filter, take ethyl acetate phase rotation Turn evaporation and obtain 5- methyl -3- piconols;
S3, -5 chloromethyl pyridine hydrochloride of preparation 3- methyl:By the 5- first that molar part will be obtained in 1 part of S2 - 3 piconol of base is dissolved in dioxane, 2.5 parts of thionyl chlorides of Deca, and liquid is kept during Deca Temperature be 24 DEG C, be warming up to 72 DEG C, be incubated 3.7h, do not stop in Deca and insulating process stirring, be cooled to 27 DEG C, it is evaporated under reduced pressure after removing thionyl chloride, is warming up to 65 DEG C, removing dioxane is evaporated under reduced pressure and obtains 3- - 5 chloromethyl pyridine hydrochloride of methyl;
S4, prepare Rupatadine:Filling N2In environment, by molar part by 1 part of desloratadine, 2 parts of potassium carbonate, - 5 chloromethyl pyridine hydrochloride of 3- methyl obtained in DMF and 2.5 parts of S3 is mixed, and is risen Temperature is incubated 22h to 45 DEG C, does not stop stirring in insulating process, and after adding water and mixing, add methylene chloride extraction 6 It is secondary, it is then combined with dichloromethane and mutually obtains solution E, after washing 2 stratification of solution E with water, takes upper strata Clear liquid obtains solution F, then subnatant is solution G, adds methylene chloride and is extracted, remove in solution F Layer clear liquid obtains Solution H, and by Solution H and solution G mix homogeneously, plus anhydrous sodium sulfate drying is to moisture For 0.4wt%, filter, rotary evaporation obtains Rupatadine.
Embodiment 7
A kind of preparation technology of Rupatadine, comprises the steps:
S1, preparation 5- methyinicotinates:1 part of 5- methylnicotinic acid, 16 parts of methanol are mixed by molar part, 3 parts of thionyl chlorides of Deca, thionyl chloride completion of dropping in the 20min, are warming up to 82 DEG C, are incubated 6h, drop Plus with insulating process in do not stop stirring, adjust the temperature to 55 DEG C, be evaporated under reduced pressure and remove methanol and thionyl chloride, Room temperature is cooled to, adds frozen water to obtain solution A;In ice bath, the pH=8 of solution A is adjusted with ammonia, plus Ethyl acetate is extracted, and adds anhydrous sodium sulfate drying to moisture to be 0.3wt%, filter in ethyl acetate phase, Take ethyl acetate phase rotary evaporation and obtain 5- methyinicotinates;
S2, preparation 5- methyl -3- piconols:By molar part by 2 parts of magnesium chlorides, 2 parts of potassium borohydrides, four Hydrogen furan is mixed, and is warming up to 67 DEG C, and flow back 2h, is cooled to room temperature and obtains solution B;By what is obtained in S1 5- methyinicotinates are dissolved in adding tetrahydrofuran, and it is 40 DEG C to adjust temperature, Deca solution B, solution B The completion of dropping in the 1.3h, is incubated 1h, does not stop stirring, be cooled to room temperature and obtain molten in Deca and insulating process Liquid C;Add methanol that reaction is quenched, be warming up to 40 DEG C, rotary evaporation removes tetrahydrofuran and methanol obtains dense Contracting thing D;Add water in concentrate D after mixing, plus ethyl acetate extraction, coextraction three times, merge acetic acid second Ester phase, plus anhydrous sodium sulfate drying to moisture be 0.3wt%, filter, take ethyl acetate phase rotation steam Send out and obtain 5- methyl -3- piconols;
S3, -5 chloromethyl pyridine hydrochloride of preparation 3- methyl:By the 5- first that molar part will be obtained in 1 part of S2 - 3 piconol of base is dissolved in dioxane, 2 parts of thionyl chlorides of Deca, and liquid is kept during Deca Temperature is 25 DEG C, is warming up to 70 DEG C, is incubated 4h, does not stop stirring, be cooled to 25 DEG C in Deca and insulating process, It is evaporated under reduced pressure after removing thionyl chloride, is warming up to 70 DEG C, removing dioxane is evaporated under reduced pressure and obtains 3- methyl -5 Chloromethyl pyridine hydrochloride;
S4, prepare Rupatadine:Filling N2In environment, by molar part by 1 part of desloratadine, 2.5 parts of carbonic acid - 5 chloromethyl pyridine hydrochloride of 3- methyl obtained in potassium, DMF and 2 parts of S3 is mixed, 50 DEG C are warming up to, 20h is incubated, in insulating process, do not stop stirring, after adding water and mixing, add methylene chloride extraction Take 5 times, be then combined with dichloromethane and mutually obtain solution E, wash solution E 2 times with water, take the supernatant and obtain To solution F, then subnatant is solution G, adds methylene chloride and is extracted, take subnatant in solution F Solution H is obtained, by Solution H and solution G mix homogeneously, plus anhydrous sodium sulfate drying to moisture is 0.3wt%, filters, and rotary evaporation obtains Rupatadine.
Embodiment 1 and embodiment 2 are not provided proportioning raw materials situation, i.e. raw material and can be reacted with arbitrary proportion, Because ratio change does not generally affect the carrying out reacted, the height of yield is simply influenced whether.
Fusing point, purity test calculated yield are carried out to embodiment 3-7, it is as a result as shown in the table:
The Rupatadine purity height for preparing of the invention can be obtained by upper table, yield is good.
The above, the only present invention preferably specific embodiment, but protection scope of the present invention not office Be limited to this, any those familiar with the art the invention discloses technical scope in, according to this The technical scheme of invention and its inventive concept in addition equivalent or change, should all cover the protection in the present invention Within the scope of.

Claims (10)

1. a kind of preparation technology of Rupatadine, it is characterised in that comprise the steps:
S1, preparation 5- methyinicotinates:5- methylnicotinic acids, methanol are mixed, Deca thionyl chloride rises Temperature, insulation, Evaporation of methanol and thionyl chloride, water on the rocks obtain solution A;The pH=7-9 of solution A is adjusted, Plus first organic solvent extraction, take organic faciess evaporation obtain 5- methyinicotinates;
S2, preparation 5- methyl -3- piconols:Magnesium chloride, potassium borohydride, tetrahydrofuran are mixed, is risen Temperature backflow, is cooled to room temperature and obtains solution B;The 5- methyinicotinates obtained in S1 are added into tetrahydrofuran Middle dissolving, adjusts temperature, and Deca solution B, insulation are cooled to room temperature and obtain solution C;Methanol is added to be quenched Reaction, evaporation tetrahydrofuran and methanol obtain concentrate D;Add water in concentrate D after mixing, plus the second Organic solvent is extracted, and is taken organic faciess evaporation and is obtained 5- methyl -3- piconols;
S3, -5 chloromethyl pyridine hydrochloride of preparation 3- methyl:By -3 piconol of 5- methyl obtained in S2 It is dissolved in dioxane, Deca thionyl chloride, the temperature that liquid is kept during Deca is 20-30 DEG C, Heat up, insulation, evaporation obtain -5 chloromethyl pyridine hydrochloride of 3- methyl;
S4, prepare Rupatadine:Filling N2In environment, by desloratadine, potassium carbonate, N, N dimethyl first - 5 chloromethyl pyridine hydrochloride of 3- methyl obtained in amide and S3 is mixed, and is heated up, insulation, adds water to mix It is even, plus the extraction of the 3rd organic solvent, take organic faciess evaporation and obtain Rupatadine.
2. the preparation technology of Rupatadine according to claim 1, it is characterised in that in S1,5- first Base nicotinic acid is 1 with the mol ratio of methanol:10-20.
3. according to claim 1 or the preparation technology of 2 Rupatadines, it is characterised in that in S1, 5- methylnicotinic acids are 1 with the mol ratio of thionyl chloride:1-5.
4. according to any one of claim 1-3 Rupatadine preparation technology, it is characterised in that S1 In, 5- methylnicotinic acids, methanol are mixed, Deca thionyl chloride is warming up to 40-100 DEG C, is incubated 2.5-7.5h, Do not stop stirring in Deca and insulating process, adjust the temperature to 50-60 DEG C, be evaporated under reduced pressure and remove methanol and chlorination Sulfoxide, is cooled to room temperature, adds frozen water to obtain solution A;In ice bath, the pH=7-9 of solution A is adjusted, Plus first organic solvent extraction, take organic faciess rotary evaporation and obtain 5- methyinicotinates;Preferably, chlorination Sulfoxide completion of dropping in the 10-30min;Preferably, the pH=7-9 of solution A is adjusted with ammonia;Preferably, First organic solvent is ethyl acetate;Preferably, plus the extraction of the first organic solvent, in organic faciess plus anhydrous sulfur Sour sodium drying is≤0.5wt% to moisture, filters, takes organic faciess rotary evaporation and obtain 5- methylnicotinic acid first Ester.
5. according to any one of claim 1-4 Rupatadine preparation technology, it is characterised in that S2 In, the mol ratio of 5- methyinicotinates, magnesium chloride and potassium borohydride is 1:1-5:1-5, wherein, chlorine The mol ratio for changing magnesium and potassium borohydride is 1:1.
6. according to any one of claim 1-5 Rupatadine preparation technology, it is characterised in that S2 In, magnesium chloride, potassium borohydride, tetrahydrofuran are mixed, 65-70 DEG C is warming up to, flow back 0.5-4.5h, It is cooled to room temperature and obtains solution B;The 5- methyinicotinates obtained in S1 are added in tetrahydrofuran and are dissolved, It is 0-80 DEG C to adjust temperature, and Deca solution B is incubated 0.5-1.5h, does not stop stirring in Deca and insulating process, It is cooled to room temperature and obtains solution C;Add methanol that reaction is quenched, be warming up to 35-45 DEG C, rotary evaporation removes four Hydrogen furan and methanol obtain concentrate D;Add water in concentrate D after mixing, plus the extraction of the second organic solvent, Take organic faciess rotary evaporation and obtain 5- methyl -3- piconols;Preferably, solution B Deca in the 0.5-2h Finish;Preferably, the second organic solvent is ethyl acetate;Preferably, plus the extraction of the second organic solvent, altogether Extraction three times, merges organic faciess, plus anhydrous sodium sulfate drying is filtered to being≤0.5wt% to moisture, Take organic faciess rotary evaporation and obtain 5- methyl -3- piconols.
7. according to any one of claim 1-6 Rupatadine preparation technology, it is characterised in that S3 In, the mol ratio of -3 piconol of 5- methyl and thionyl chloride is 1:1-3.
8. according to any one of claim 1-7 Rupatadine preparation technology, it is characterised in that S3 In, -3 piconol of 5- methyl obtained in S2 is dissolved in dioxane, Deca thionyl chloride, is dripped Plus during keep the temperature of liquid to be 20-30 DEG C, be warming up to 60-80 DEG C, be incubated 3-5h, Deca and guarantor Stirring is not stopped during temperature, reduction vaporization obtains -5 chloromethyl pyridine hydrochloride of 3- methyl;Preferably, it is incubated Do not stop stirring in 3-5h, Deca and insulating process, be cooled to 20-30 DEG C, be evaporated under reduced pressure and remove thionyl chloride Afterwards, 60-80 DEG C is warming up to, removing dioxane is evaporated under reduced pressure and is obtained -5 chloromethyl pyridine hydrochloride of 3- methyl.
9. according to any one of claim 1-8 Rupatadine preparation technology, it is characterised in that S4 In, desloratadine, potassium carbonate, the mol ratio of -5 chloromethylpyridine hydrochloric acid of 3- methyl are 1:1-4:1-3.
10. according to any one of claim 1-9 Rupatadine preparation technology, it is characterised in that S4 In, filling N2In environment, by what is obtained in desloratadine, potassium carbonate, DMF and S3 - 5 chloromethyl pyridine hydrochloride of 3- methyl is mixed, and is warming up to 35-65 DEG C, is incubated 15-25h, in insulating process Do not stop stirring, add water and mix, plus the extraction of the 3rd organic solvent, take organic faciess rotary evaporation and obtain Lu Pata It is fixed;Preferably, the 3rd organic solvent is dichloromethane;Preferably, add water and mix, plus the 3rd organic molten Agent carries out at least 1 time extraction, is then combined with organic faciess and obtains solution E, washes solution E 2-3 time with water, After stratification, take the supernatant and obtain solution F, then subnatant is solution G, add the 3rd in solution F Organic solvent is extracted, and is taken subnatant and is obtained Solution H, and Solution H and solution G mix homogeneously revolve Turn evaporation and obtain Rupatadine;Preferably, plus the extraction of the 3rd organic solvent, in organic faciess plus anhydrous sodium sulfate It is≤0.5wt% to be dried to moisture, filters, takes organic faciess rotary evaporation and obtain Rupatadine.
CN201610069504.8A 2016-01-28 2016-01-28 Rupatadine preparation proces Pending CN106560471A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610069504.8A CN106560471A (en) 2016-01-28 2016-01-28 Rupatadine preparation proces

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610069504.8A CN106560471A (en) 2016-01-28 2016-01-28 Rupatadine preparation proces

Publications (1)

Publication Number Publication Date
CN106560471A true CN106560471A (en) 2017-04-12

Family

ID=58485498

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610069504.8A Pending CN106560471A (en) 2016-01-28 2016-01-28 Rupatadine preparation proces

Country Status (1)

Country Link
CN (1) CN106560471A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110713481A (en) * 2019-11-29 2020-01-21 杭州澳医保灵药业有限公司 Preparation method of rupatadine
CN113121420A (en) * 2021-05-19 2021-07-16 北京嘉林药业股份有限公司 Preparation method of rupatadine fumarate intermediate 5-methyl-3-chloromethyl pyridine hydrochloride
CN114920727A (en) * 2022-05-26 2022-08-19 重庆华邦制药有限公司 Preparation method of rupatadine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103804357A (en) * 2014-01-02 2014-05-21 珠海金鸿药业股份有限公司 Rupatadine fumarate compound as well as synthesis method and pharmaceutical composition thereof
CN104163786A (en) * 2014-06-10 2014-11-26 上海应用技术学院 Method for preparing 5-methyl-3-bromomethylpyridine hydrobromide

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103804357A (en) * 2014-01-02 2014-05-21 珠海金鸿药业股份有限公司 Rupatadine fumarate compound as well as synthesis method and pharmaceutical composition thereof
CN104163786A (en) * 2014-06-10 2014-11-26 上海应用技术学院 Method for preparing 5-methyl-3-bromomethylpyridine hydrobromide

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
李六林等: "富马酸卢帕他定的合成", 《中国现代应用药学》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110713481A (en) * 2019-11-29 2020-01-21 杭州澳医保灵药业有限公司 Preparation method of rupatadine
CN113121420A (en) * 2021-05-19 2021-07-16 北京嘉林药业股份有限公司 Preparation method of rupatadine fumarate intermediate 5-methyl-3-chloromethyl pyridine hydrochloride
CN114920727A (en) * 2022-05-26 2022-08-19 重庆华邦制药有限公司 Preparation method of rupatadine
CN114920727B (en) * 2022-05-26 2023-07-25 重庆华邦制药有限公司 Preparation method of rupatadine

Similar Documents

Publication Publication Date Title
CN106560471A (en) Rupatadine preparation proces
CN105566215B (en) A kind of Rui Gefeini preparation method
CN105859615A (en) Novel preparation method and novel intermediate of dequalinium chloride
CN103724258B (en) Preparation method of sorafenib
CN103524788A (en) Carbonizing agent for halogen-free expansion flame-retardant system and preparation method of carbonizing agent
CN105254575A (en) Synthetic method for sulfadiazine
CN104628679B (en) Bitopertin synthetic method and its intermediate
CN107573333A (en) The preparation method of intermediate of ticagrelor and preparation method thereof and ticagrelor
CN101531654B (en) Preparation method for Rupatadine
CN103739604B (en) A kind of preparation method of applicable industry's enlarging production Pralatrexate
CN106380450A (en) Method for preparing low-energy consumption imidazoles ionic liquid
CN102174007A (en) Industrial preparation method of [2-(2-cyano-pyrrolidine-1-yl)-2-oxo-ethyl]-tert-butyl carbamate
CN104163786A (en) Method for preparing 5-methyl-3-bromomethylpyridine hydrobromide
CN106431800B (en) (E) synthetic method of -4- oxo -2- butylene aldehyde compound
CN106892863A (en) The preparation method of vismodegib and its intermediate
CN100376551C (en) Semicarbazone synthesis method
CN106008392B (en) A kind of preparation method of the intermediate of cancer therapy drug Dasatinib
CN101768140B (en) Preparation method of cinepazide maleate
CN105017363B (en) 3-ketone-4-androstene-17 β carboxylic acid and the synthetic method of methyl ester thereof
CN105646532B (en) A kind of synthetic method of diaza spiro [5.6] dodecane of 2 tertbutyloxycarbonyl, 10 carbonyl, 8 oxo 2,11
CN107353307A (en) A kind of dichloro(Ethylenediamine)Close the preparation method of palladium
CN107286132A (en) A kind of preparation method for anatabine
CN102212042A (en) Synthetic method of tetra-azacrown ether
CN103664584B (en) Method for preparing a-fluoro-propionyl acetate
CN114685401A (en) Synthesis method of di (4-methylpiperazine-1-yl) ketone

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20170412